Actinium Pharmaceuticals Inc (NYSE American:ATNM)
| 4.85 BATS BZX Real-Time Price As of 11:52am ET |  -0.12 / -2.41%Today’s Change | 4.41 Today|||52-Week Range 10.30 | -19.30% Year-to-Date |
Latest ATNM News | Press Releases
No recent news for Actinium Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.97 |
| Today’s open | 4.85 |
| Day’s range | 4.84 - 4.86 |
| Volume | 48,361 |
| Average volume (3 months) | 662,927 |
| Market cap | $121.5M |
Data as of 11:52am ET, 06/30/2022
Growth & Valuation
| Earnings growth (last year) | +34.21% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 108.06 |
| Price/Book | 1.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OTICOtonomy Inc | +0.01 | +0.48% |
| CTMXCytomX Therapeutics ... | -0.01 | -0.53% |
| CLLSCellectis SA | +0.01 | +0.34% |
| ENDPEndo International P... | -0.07 | -13.86% |
Data as of 12:33pm ET, 06/30/2022
Financials
| Next reporting date | August 1, 2022 |
| EPS forecast (this quarter) | $0.80 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$24.8M |
| Net profit margin | -2,165.56% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
